Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A strategy for screening anti-tumor drugs utilizing oncogenes encoded in retroviral vectors.

A strategy for screening anti-tumor drugs utilizing oncogenes encoded in retroviral vectors. Int J Cancer. 1996 Jun 11; 66(6):753-9.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.